Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors

• Autor(es): Chícharo, Ana Teodósio ; Lopes, Ana R. ; Barreira, Sofia ; Pinto, Luísa ; Machado, Ana R. Cruz ; Capela, Susana
• Data: 2024
• Identificador Persistente: http://hdl.handle.net/10400.1/26402
• Origem: Sapientia - Universidade do Algarve
• Assunto(s): Pregnancy; Rheumatic disorders; Mothers; Perinatal period; Tumor necrosis factor inhibitors; Biosimilar pharmaceuticals
• Tipo de Documento: Artigo científico
• Idioma: Inglês
• Contribuidor(es): Sapientia

Descrição

No safety or efficacy issues arose from using biosimilar TNFi during conception or pregnancy.